Market Access
Policy in Focus: What’s new with CMS drug price negotiation,...
Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.
R&D
CAMP4 on a new class of ASO in gene under expression
CAMP4 Therapeutics CFO Kelly Gold discusses developments in antisense oligonucleotides and CAMP4’s CMP-002 study
Sales & Marketing
BonelliErede on M&A in Europe: Andrea Carta Mantiglia
Andrea Carta Mantiglia, partner and lead of the Healthcare & Life Sciences Focus Team at Italian law firm BonelliErede, discusses M&A in Europe.
R&D
Purespring on nephrology & gene therapy in kidney disease
Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
